We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Thermo Fisher Scientific Inc | NYSE:TMO | NYSE | Common Stock |
| Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 573.55 | 124 | 13:34:15 |
From May 2019 to May 2024
By Josh Beckerman
Biocept Inc. shares rose 72% to 61 cents following the company's announcement late Thursday that it will conduct Covid-19 testing.
Biocept, which provides liquid biopsy tests for cancer patients, said it would begin accepting physician-ordered Covid-19 testing requests for processing April 15.
Biocept's lab will use Thermo Fisher Scientific Inc.'s TaqPath platform and kit.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
April 13, 2020 13:05 ET (17:05 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
1 Year Thermo Fisher Scientific Chart |
1 Month Thermo Fisher Scientific Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
